Belgium vs France: Cause of death, by non-communicable diseases, ages 5-14, male
Belgium
65.8%
in 2021
France
63.0%
in 2021
Belgium rank
19th
France rank
22nd
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Belgium
- France
How they compare
Belgium currently reports 65.8% against 63.0% in France, a difference of 2.8%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was France ahead.
Belgium ranks 19th and France ranks 22nd of 185 countries.
Across the 3 decades both report, Belgium averaged higher in 1 and France in 2.
Head to head by decade
| Decade | Belgium | France | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.1% | 47.6% | 6.5% | France |
| 2010s | 58.5% | 65.7% | 7.3% | France |
| 2020s | 66.1% | 61.2% | 4.9% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Belgium or France?
- Belgium, at 65.8% against 63.0% in France as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Belgium and France?
- 2.8%, with Belgium ahead.
- How many years of comparable data are there for Belgium and France?
- 6 years are reported by both, from 2000 to 2021.
- How do Belgium and France rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Belgium ranks 19th and France ranks 22nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.